Zhejiang Normal University "School-Enterprise Through Train" First Station Enters Jinxi Factory
Release time:
2020-08-14
Zhejiang Normal University's "school-enterprise through train" first stop entered Jinxi Factory
News from our newspaper 3# July 22 , the "school-enterprise through train" jointly organized by the Municipal Human Resources and Social Security Bureau and Zhejiang Normal University entered Jinxi Pharmaceutical Factory at the first stop.
Liu Hong, Deputy Director of Jinhua Employment Administration, Ma Li, Deputy Director of the Student Affairs Department of Zhejiang Normal University, Sun Meihao, Vice President of the College of Chemistry and Life Sciences, and Xiao Xiaohui, Director of the Department of Chemistry of the College, together with nearly 40 students majoring in applied chemistry and biotechnology, visited the production process of pharmaceutical enterprises and had face-to-face communication with the heads of the enterprises.
"This is a wastewater treatment tank. The wastewater in our factory is treated and discharged after reaching the standard." "What you see over there is an incinerator, which is responsible for tail gas treatment. Once the factory is opened, it will always be open."... Zheng Kunwu, director of Jinxi Factory, led the students to visit the raw material workshop, comprehensive warehouse, sewage treatment station, cephalosporin preparation workshop and other sites, introduced the pharmaceutical production facilities and equipment, product production technology and process, waste water and waste gas treatment principles and measures, product storage requirements, etc., and answered the questions raised by the students one by one.
In the conference room of Jinxi Factory, teachers and students had discussions with Jin Huazhong, Secretary of the Party Committee of the Pharmaceutical Company, Zhang Weidong, Quality Director, Zheng Kunwu, Director of Jinxi Factory, and the backbone of the enterprise. On behalf of the pharmaceutical company, Jin Huazhong welcomed the arrival of the teachers and students and introduced the basic situation of the pharmaceutical company. The college students raised many questions about employee training, job skills improvement, employee promotion, etc., and the leaders present also answered them. Yang Xinfeng, director of the raw material workshop of
Jinxi Factory, Liu Bin, deputy director, Zheng Nan, Wu Minzhe, craftsman Tu Liaobo, and Song Xinhua, head of the central laboratory, participated in the discussion as representatives of college students and staff. Based on their own work experience, they talked about their personal feelings after walking out of the campus and stepping into the society from the aspects of work, people and interpersonal relationships, it won the applause of the normal university students. It is understood that the "school-enterprise through train" activity of Zhejiang Normal University takes "entering famous enterprises and talking to senior executives" as its main theme, and organizes teachers and students of Zhejiang Normal University to visit famous enterprises in batches and categories, so as to enable students to understand the enterprise culture, grasp the trend of enterprise talent demand, and make clear their life plans as early as possible. (Reporter Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page